Results 1 to 10 of 274
Hybrid View
-
10-22-2014, 06:18 AM #1
It has probably been studied. However, there are countless strains of such bad germs. They're studied, and then stored away. Vaccine development at significant quantities costs oodles of money. Making medicine even more so. I work for a big pharma company; I know how much it costs. To bring an approved product to market costs hundreds of millions, and about 7 years, assuming that you already have a running plant you can use. There are so many of those bugs, and the risk of such a bug going pandemic is so low that literally noone is going to spend any money on production or even developing ramp-up scenarios.
The notion that they can just pick something out of a closet and say 'here it is', is completely wrong. They may have some untested, experimental stuff in very low quantities, that has never gone through human trial. When it's gone, it's gone. That is why only a couple of health workers got it so far. People have been treated with it. There is none to spare. Even to make a raw batch of untested, unvalidated take-at-own-risk vaccine or medicine could take half a year, depending on just how it is made. The stuff we make, takes months. If the product hasn't been made the the processes have been shelved for a while, it could be much longer. Because manufacture of many such treatments rely on biological processes, it is vastly more complex and time consuming than mixing up a batch of aspirin. At this point in time, the handful of survivors donate a lot of plasma because that is the best bet for now. Basically, their bodies produce the antibodies that we'd need for a treatment. And reproducing this process in a bioreactor is very costly, very time consuming to get right, and very difficult. As I said, hundreds of millions and 7 years, which is why there is no commercial stuff nor the resources to ramp up quickly.
Also, while there has been some research into hemorrhagic fevers, all big players have abandoned it for weapons use (except for the ones that have known to be developed at some point in the past, which is why soldiers still get innoculated against smallpox). A fever that would be a great weapon would also be so uncontrollable that you may just end up liquidating your own army or population. Anthrax and other such nasties is where the research is at: things that can be controlled and targeted accurately.Til shade is gone, til water is gone, Into the shadow with teeth bared, screaming defiance with the last breath.
To spit in Sightblinder’s eye on the Last Day
-
10-22-2014, 07:55 AM #2
Agree with all this. But a few points - I'm not a fan of the monopolies that pharm companies have here in the US. Take the hep C treatment - it's $20k/pill here, but costs about 1% of that in India because the drug companies don't have a patent monopoly there. Although pharm companies do have to spend money to get the drugs through FDA, there's is MILLIONS to BILLIONS spent in basic research through tax dollars that lead up to that. A big reason that our healthcare costs are so far above the rest of the world's is that we allow patent monopolies on drugs. Also, like you said, ebola is not good for weaponizing. It's not easily spread and the quickness of the lethality makes it unlikely to become very widespread.